Clinical trial
Varenicline Adjunctive Treatment in Schizophrenia
NCT00492349 · University of Maryland, Baltimore, Other · Completed
Key facts
| NCT number | NCT00492349 |
|---|---|
| Title | Varenicline Adjunctive Treatment in Schizophrenia |
| Official title | Varenicline Adjunctive Treatment in Schizophrenia |
| Lead sponsor | University of Maryland, Baltimore, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder |
| Intervention type | Drug |
| Interventions | Varenicline, Placebo |
| Enrollment | 91 |
| Start date | May 1, 2007 |
| Primary completion | May 1, 2010 |
| Completion | Apr 1, 2011 |
| First posted | Jun 27, 2007 |
| Last update posted | Jan 5, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: